MONOCLONAL ANTIBODY-BASED THERAPEUTICS FOR TARGETING MMPS AND DIABETIC NEUROPATHY

$1,601,314FY2021Defense Health AgencyDOD

Duke University, Durham NC

Investigators

View source on USAspending →